Psychedelics and the environment
Many studies have found that people who use psychedelics are more likely to have pro-environmental behavior and ecology beliefs when compared to other people. A recent study by the University…
Set and setting, psychedelics and the placebo response.
Two academic disciplines that look at how non-biological variables affect the response to therapy are placebo response theory and set and setting theory. Both believe that aspects like expectations, planning,…
Psychedelic Formulary
Am·phet·amines(RS)-1-PHENYLPROPAN-2-AMINEAmphetamines are a strong physical and mental stimulants that are available widely in both prescription and street forms. Their effects are very stimulating, suppressing human needs like appetite or rest…
Psychedelic Comparison
What are the differences between psychedelics? A comparison of the popularity of substances listed on Erowid (from 10,387 trip reports). Mental health disorders are on the rise, whilst the development…
Psilocybin availability in the UK
When will psilocybin be legally available in the UK? It is no secret in the medical sector, that evidence for the efficacy of traditional antidepressants (SSRIs, SNRIs, NASSAs...) is underwhelming.…
Can pharmacists prescribe cannabis-based medicines?
Who can prescribe cannabis in the UK? Currently, prescribing pharmacists in the UK cannot prescribe cannabis-based products for medicinal use (CBPMs). Prescribing of CBPMs for medicinal use in the UK…
Esketamine as an Antidepressant
Major depressive disorder (MDD) is a significant cause of disability worldwide and the most common illness preceding suicide. On March 5, 2019, the nasal spray drug, esketamine, also known as Spravato (by Janssen…
Esketamine availability in Australia
Spravato is the brand name of esketamine, a glutamate receptor drug used for rapid depression treatment manufactured by Johnson & Johnson in the US. Esketamine is contained within the standard pharmaceutical…
Esketamine availability in the UK
Spravato is the brand name of esketamine, a nasally adminitsered medicine used for the rapid treatment of moderate to severe depression. Spravato was initially released by Johnson & Johnson in…